Physician Response to Implementation of Genotype-Tailored Antiplatelet Therapy

Physician responses to genomic information are vital to the success of precision medicine initiatives. We prospectively studied a pharmacogenomics implementation program for the propensity of clinicians to select antiplatelet therapy based on CYP2C19 loss-of-function (LOF) variants in stented patien...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Pharmacol Ther
Главные авторы: Peterson, Josh F., Field, Julie R., Unertl, Kim, Schildcrout, Jonathan S., Johnson, Daniel C., Shi, Yaping, Danciu, Ioana, Cleator, John H., Pulley, Jill M., McPherson, John A., Denny, Josh C., Laposata, Michael, Roden, Dan M., Johnson, Kevin B.
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899238/
https://ncbi.nlm.nih.gov/pubmed/26693963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.331
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы